AB
EIGR

Amalgamated Bank’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Amalgamated Bank’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-221
Closed -$6K – 3163
2023
Q1 		$6K Buy
221
+4
+2% +$186 ﹤0.01% 2888
2022
Q4 		$8K Hold
217
– – ﹤0.01% 2905
2022
Q3 		$49K Buy
217
+5
+2% +$1.23K ﹤0.01% 2475
2022
Q2 		$40K Buy
212
+83
+64% +$16.7K ﹤0.01% 2594
2022
Q1 		$32K Buy
+129
New +$20.4K ﹤0.01% 2659

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Amalgamated Bank's EIGR Position: Q2 2023 in Review

Amalgamated Bank sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q2 2023, closing a stake of 221 shares — an estimated $6K sold.

Amalgamated Bank first reported a position in EIGR in Q1 2022 and held it in 5 quarters. The position peaked at $49K in Q3 2022. 66 funds tracked by Wall St. Rank hold EIGR as of Q2 2023.

  • Amalgamated Bank reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Amalgamated Bank sold 221 Eiger BioPharmaceuticals, Inc. shares in Q2 2023, an estimated $6K.
  • Amalgamated Bank first reported a position in Eiger BioPharmaceuticals, Inc. in Q1 2022 and held it in 5 quarters.
  • Amalgamated Bank's Eiger BioPharmaceuticals, Inc. position peaked at $49K in Q3 2022.
  • 66 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q2 2023.

Based on Amalgamated Bank's 13F filing for Q2 2023, filed 11 Aug 2023.